PacBio to Report Q1 2026 Earnings on May 7

Got story updates? Submit your updates here. ›

PacBio, a leading life science technology company, announced that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and available on the company's investor relations website.

Why it matters

As a major player in the genomics and sequencing industry, PacBio's quarterly earnings calls provide important updates on the company's financial performance, product development, and strategic direction. These calls are closely watched by investors, analysts, and others in the life sciences community.

The details

PacBio designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The company's products and technologies, including its HiFi long-read sequencing, address a broad set of research applications such as human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging areas.

• The conference call will be held on Thursday, May 7, 2026 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
• PacBio will report its first quarter 2026 financial results on the call.

What’s next

Investors and analysts will be closely watching PacBio's Q1 2026 earnings call for updates on the company's financial performance, product roadmap, and market positioning.